Olga Pirogova Sells 548 Shares of Azenta, Inc. (NASDAQ:AZTA) Stock

Azenta, Inc. (NASDAQ:AZTA) SVP Olga Pirogova sold 548 shares of the stock in a transaction on Tuesday, November 19th. The shares were sold at an average price of $40.07, for a total value of $21,958.36. Following the completion of the sale, the senior vice president now owns 19,373 shares in the company, valued at approximately $776,276.11. The trade was a 2.75 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Azenta Stock Performance

Shares of NASDAQ AZTA opened at $45.16 on Friday. The stock’s 50-day simple moving average is $45.22 and its 200-day simple moving average is $50.08. The firm has a market capitalization of $2.21 billion, a PE ratio of -15.21 and a beta of 1.48. Azenta, Inc. has a fifty-two week low of $38.82 and a fifty-two week high of $69.16.

Azenta (NASDAQ:AZTA) last issued its quarterly earnings data on Tuesday, November 12th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.10 by $0.08. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%. The business had revenue of $170.00 million during the quarter, compared to the consensus estimate of $169.66 million. During the same quarter in the previous year, the firm earned $0.13 EPS. The company’s revenue was down 1.2% compared to the same quarter last year. On average, sell-side analysts forecast that Azenta, Inc. will post 0.4 earnings per share for the current fiscal year.

Institutional Trading of Azenta

Hedge funds and other institutional investors have recently made changes to their positions in the company. Kayne Anderson Rudnick Investment Management LLC grew its stake in Azenta by 1.9% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,298,040 shares of the company’s stock worth $278,783,000 after buying an additional 100,826 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Azenta by 16.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 2,970,964 shares of the company’s stock valued at $156,331,000 after acquiring an additional 421,719 shares during the period. State Street Corp increased its holdings in shares of Azenta by 0.4% in the 3rd quarter. State Street Corp now owns 1,686,993 shares of the company’s stock valued at $81,718,000 after acquiring an additional 6,398 shares during the period. Allspring Global Investments Holdings LLC raised its position in Azenta by 16.4% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,298,856 shares of the company’s stock valued at $62,917,000 after purchasing an additional 183,040 shares during the last quarter. Finally, Royce & Associates LP boosted its stake in Azenta by 7.8% during the 3rd quarter. Royce & Associates LP now owns 739,977 shares of the company’s stock worth $35,844,000 after purchasing an additional 53,584 shares during the period. Institutional investors and hedge funds own 99.08% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on AZTA. Needham & Company LLC decreased their price objective on Azenta from $69.00 to $55.00 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Evercore ISI lowered their price target on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a report on Tuesday, October 1st. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $63.60.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.